Gevo Inc Net Assets
Gevo Inc net assets. Based on the latest financial reports, Gevo Inc (GEVO) has net assets worth $280.95 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($490.71 Million) and total liabilities ($209.76 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore GEVO year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $280.95 Million |
| % of Total Assets | 57.25% |
| Annual Growth Rate | 34.24% |
| 5-Year Change | -13.9% |
| 10-Year Change | 580.25% |
| Growth Volatility | 130.54 |
Net Assets of Gevo Inc (2008–2025)
Net assets of Gevo Inc from 2008 to 2025. This chart illustrates how Gevo Inc's net assets have evolved over time, based on quarterly financial data. See how leveraged is Gevo Inc's balance sheet to measure how much of total assets are equity-financed.
Annual Net Assets for Gevo Inc (2008–2025)
The table below shows the annual net assets of Gevo Inc from 2008 to 2025. For live market cap and overall valuation, see market cap of Gevo Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $471.17 Million | -3.74% |
| 2024-12-31 | $489.49 Million | -12.18% |
| 2023-12-31 | $557.39 Million | -7.94% |
| 2022-12-31 | $605.48 Million | +10.64% |
| 2021-12-31 | $547.25 Million | +273.86% |
| 2020-12-31 | $146.38 Million | +101.89% |
| 2019-12-31 | $72.50 Million | -18.34% |
| 2018-12-31 | $88.79 Million | +39.75% |
| 2017-12-31 | $63.53 Million | -8.28% |
| 2016-12-31 | $69.26 Million | +42.45% |
| 2015-12-31 | $48.62 Million | +3.53% |
| 2014-12-31 | $46.96 Million | -33.83% |
| 2013-12-31 | $70.97 Million | -27.45% |
| 2012-12-31 | $97.83 Million | +6.18% |
| 2011-12-31 | $92.14 Million | +361.63% |
| 2010-12-31 | $19.96 Million | +32.33% |
| 2009-12-31 | $15.08 Million | +377.61% |
| 2008-12-31 | $3.16 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Gevo Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 81101500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Gevo Inc Net Assets Breakdown (December 2025)
Gevo Inc net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.42 Million | 0.52% |
| Other Components | $1.30 Billion | 278.35% |
| Total Equity | $466.34 Million | 100.00% |
Gevo Inc Competitors by Market Cap
The table below lists competitors of Gevo Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Surgical Science Sweden AB
ST:SUS
|
$338.53 Million |
|
LIBERTY LAT.AMER.A DL-01
F:1LL
|
$338.65 Million |
|
Chemclin Diagnostics Co. Ltd. A
SHG:688468
|
$338.67 Million |
|
HiVi Acoustics Technology Co Ltd
SHE:002888
|
$338.76 Million |
|
Danhua Chemical Technology Co Ltd A
SHG:600844
|
$338.30 Million |
|
Suzhou Institute of Building Science Group Co Ltd
SHG:603183
|
$338.28 Million |
|
BlackRock TCP Capital Corp
NASDAQ:TCPC
|
$338.13 Million |
|
Shaanxi Meibang Pharmaceutical Group Co Ltd
SHG:605033
|
$338.11 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Gevo Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 489,488,000 to 466,337,000, a change of -23,151,000 (-4.7%).
- Net loss of 33,836,000 reduced equity.
- Other factors increased equity by 10,685,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-33.84 Million | -7.26% |
| Other Changes | $10.69 Million | +2.29% |
| Total Change | $- | -4.73% |
Book Value vs Market Value Analysis
This analysis compares Gevo Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.70x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.00x to 0.70x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | $1583.75 | $1.39 | x |
| 2009-12-31 | $5666.04 | $1.39 | x |
| 2010-12-31 | $4860.94 | $1.39 | x |
| 2011-12-31 | $24132.27 | $1.39 | x |
| 2012-12-31 | $17996.87 | $1.39 | x |
| 2013-12-31 | $9449.47 | $1.39 | x |
| 2014-12-31 | $3500.86 | $1.39 | x |
| 2015-12-31 | $1378.30 | $1.39 | x |
| 2016-12-31 | $360.05 | $1.39 | x |
| 2017-12-31 | $77.97 | $1.39 | x |
| 2018-12-31 | $18.21 | $1.39 | x |
| 2019-12-31 | $5.95 | $1.39 | x |
| 2020-12-31 | $2.57 | $1.39 | x |
| 2021-12-31 | $2.80 | $1.39 | x |
| 2022-12-31 | $2.73 | $1.39 | x |
| 2023-12-31 | $2.34 | $1.39 | x |
| 2024-12-31 | $2.11 | $1.39 | x |
| 2025-12-31 | $1.99 | $1.39 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Gevo Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -7.26%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -21.07%
- • Asset Turnover: 0.22x
- • Equity Multiplier: 1.54x
- Recent ROE (-7.26%) is above the historical average (-78.75%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -460.48% | -6991.35% | 0.02x | 4.15x | $-14.86 Million |
| 2009 | -131.84% | -3012.88% | 0.03x | 1.75x | $-21.39 Million |
| 2010 | -200.97% | -244.65% | 0.32x | 2.59x | $-42.11 Million |
| 2011 | -52.33% | -74.69% | 0.49x | 1.44x | $-57.43 Million |
| 2012 | -62.06% | -248.97% | 0.16x | 1.60x | $-70.50 Million |
| 2013 | -94.13% | -812.33% | 0.07x | 1.64x | $-73.90 Million |
| 2014 | -87.61% | -145.56% | 0.29x | 2.11x | $-45.84 Million |
| 2015 | -74.90% | -125.59% | 0.28x | 2.13x | $-41.03 Million |
| 2016 | -53.75% | -140.26% | 0.24x | 1.62x | $-44.15 Million |
| 2017 | -38.77% | -90.19% | 0.31x | 1.40x | $-30.98 Million |
| 2018 | -31.51% | -85.13% | 0.31x | 1.21x | $-36.85 Million |
| 2019 | -39.53% | -117.20% | 0.26x | 1.29x | $-35.91 Million |
| 2020 | -27.45% | -725.90% | 0.04x | 1.04x | $-54.82 Million |
| 2021 | -10.82% | -11107.50% | 0.00x | 1.18x | $-113.93 Million |
| 2022 | -16.19% | -8341.02% | 0.00x | 1.16x | $-158.55 Million |
| 2023 | -11.88% | -384.97% | 0.03x | 1.17x | $-121.95 Million |
| 2024 | -16.07% | -464.91% | 0.03x | 1.19x | $-127.59 Million |
| 2025 | -7.26% | -21.07% | 0.22x | 1.54x | $-80.47 Million |
Industry Comparison
This section compares Gevo Inc's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $1,224,896,672
- Average return on equity (ROE) among peers: -2.32%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Gevo Inc (GEVO) | $280.95 Million | -460.48% | 0.75x | $338.34 Million |
| Albemarle Corp (ALB) | $1.68 Billion | 23.36% | 0.91x | $11.71 Billion |
| Alto Ingredients Inc (ALTO) | $119.26 Million | 2.58% | 0.95x | $290.10 Million |
| Aemetis Inc (AMTX) | $19.28K | -55.58% | 0.03x | $116.91 Million |
| Air Products and Chemicals Inc (APD) | $4.73 Billion | 15.06% | 1.20x | $62.29 Billion |
| Ashland Global Holdings Inc (ASH) | $3.15 Billion | 7.29% | 0.80x | $3.50 Billion |
| ASP Isotopes Inc. Common Stock (ASPI) | $51.17 Million | -63.19% | 0.84x | $318.12 Million |
| Aspen Aerogels Inc (ASPN) | $58.99 Million | -8.07% | 0.75x | $407.47 Million |
| Avient Corp (AVNT) | $978.50 Million | 24.92% | 1.99x | $3.38 Billion |
| Axalta Coating Systems Ltd (AXTA) | $1.48 Billion | 8.22% | 3.84x | $7.02 Billion |
| Balchem Corporation (BCPC) | $1.80 Million | 22.22% | 1.00x | $5.17 Billion |
About Gevo Inc
Gevo, Inc. operates as a carbon abatement company. It operates in four segments: Gevo, GevoFuels, GevoRNG, and GevoND. The company offers sustainable aviation fuel, motor fuels, and chemicals and materials; certain specialty fuels, on-road fuels, and certain products for the food chain comprising protein and feeds; hydrocarbons for gasoline, racing fuel blend stocks, and diesel fuel; ethylene and… Read more